Regulation of Treg-associated CD39 in multiple sclerosis and effects of corticotherapy during relapse
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of Treg-associated CD39 in multiple sclerosis and effects of corticotherapy during relapse
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 21, Issue 12, Pages 1533-1545
Publisher
SAGE Publications
Online
2015-02-07
DOI
10.1177/1352458514567215
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunology of Relapse and Remission in Multiple Sclerosis
- (2014) Lawrence Steinman Annual Review of Immunology
- Peripheral T Cells Are the Therapeutic Targets of Glucocorticoids in Experimental Autoimmune Encephalomyelitis
- (2014) S. Wust et al. JOURNAL OF IMMUNOLOGY
- Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients
- (2013) Laura D. Serpero et al. Journal of Neuroimmune Pharmacology
- IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39
- (2013) Ivan D Mascanfroni et al. NATURE IMMUNOLOGY
- Self-tolerance in multiple sclerosis
- (2012) R. E. Gonsette ACTA NEUROLOGICA BELGICA
- Upregulation of IL-17, but not of IL-9, in circulating cells of CIS and relapsing MS patients. Impact of corticosteroid therapy on the cytokine network
- (2012) Nathalie Muls et al. JOURNAL OF NEUROIMMUNOLOGY
- Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations
- (2012) Petra Praksova et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis
- (2011) Ying Li et al. JOURNAL OF NEUROIMMUNOLOGY
- Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse
- (2011) Evelyn Peelen et al. JOURNAL OF NEUROIMMUNOLOGY
- T Regulatory Cells Are Markers of Disease Activity in Multiple Sclerosis Patients
- (2011) Dacia Dalla Libera et al. PLoS One
- Influence of Short-Term Glucocorticoid Therapy on Regulatory T Cells In Vivo
- (2011) Silviu Sbiera et al. PLoS One
- Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate
- (2010) Ye Zheng et al. NATURE
- Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell–like and Foxp3+ regulatory T cells
- (2010) Roopali Gandhi et al. NATURE IMMUNOLOGY
- The Inflammasomes: Guardians of the Body
- (2009) Fabio Martinon et al. Annual Review of Immunology
- Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery
- (2009) Anna Dodero et al. BLOOD
- Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
- (2009) Verena Brucklacher-Waldert et al. BRAIN
- CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis
- (2009) J. M. Fletcher et al. JOURNAL OF IMMUNOLOGY
- Glucocorticoids increase CD4+CD25highcell percentage and Foxp3 expression in patients with multiple sclerosis
- (2008) M. Braitch et al. ACTA NEUROLOGICA SCANDINAVICA
- Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis
- (2007) John S. Tzartos et al. AMERICAN JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started